Today saw an important event in the evolution of the Alzheimer’s Research UK Drug Discovery Alliance with a London reception to mark the launch of the UCL Drug Discovery Institute. Part of a network of three Institutes, the UCL Drug Discovery Institute will work with its counterparts at the Universities of Oxford and Cambridge to support the translation of cutting-edge academic science towards new treatments for dementia. The event, hosted by UCL and Alzheimer’s Research UK, saw several speakers take to the stage to discuss current efforts in dementia research at the university and reflect on the importance of the charity’s investment.
UCL reception marks launch of Drug Discovery Institute
Leave a reply